LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE Drug Patent Profile
✉ Email this page to a colleague
When do Lamivudine And Tenofovir Disoproxil Fumarate patents expire, and what generic alternatives are available?
Lamivudine And Tenofovir Disoproxil Fumarate is a drug marketed by Aurobindo Pharma Ltd and is included in one NDA.
The generic ingredient in LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE is lamivudine; tenofovir disoproxil fumarate. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the lamivudine; tenofovir disoproxil fumarate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE?
- What are the global sales for LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE?
- What is Average Wholesale Price for LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE?
Summary for LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 81 |
| DailyMed Link: | LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE at DailyMed |
Recent Clinical Trials for LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | N/A |
| Prism Health North Texas | Phase 3 |
| Merck Sharp & Dohme LLC | Phase 3 |
See all LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE clinical trials
US Patents and Regulatory Information for LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | lamivudine; tenofovir disoproxil fumarate | TABLET;ORAL | 022344-001 | May 15, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
